0

Journal Articles

in Drug Therapy
 321-340 of 342 Articles
Editorial | 
Margaret A. Winker, MD; Phil B. Fontanarosa, MD
JAMA. 1999;281(18):1754-1755. doi:10.1001/jama.281.18.1754.

Medical News and Perspectives | 
JAMA. 1999;281(11):973-975. doi:10.1001/jama.281.11.973.

Commentary | 
Robert Temple, MD
JAMA. 1999;281(9):841-844. doi:10.1001/jama.281.9.841.

Special Communication | 
Timothy Brewer, MD, MPH; Graham A. Colditz, MD, DrPH
JAMA. 1999;281(9):824-829. doi:10.1001/jama.281.9.824.

Brief Report |  FREE
Kalpana Gupta, MD, MPH; Delia Scholes, PhD; Walter E. Stamm, MD
JAMA. 1999;281(8):736-738. doi:10.1001/jama.281.8.736.

Controversies | 
Matthew F. Hollon, MD
JAMA. 1999;281(4):382-384. doi:10.1001/jama.281.4.382.

Controversies | 
Alan F. Holmer, JD
JAMA. 1999;281(4):380-382. doi:10.1001/jama.281.4.380.

Medical News and Perspectives | 
JAMA. 1999;281(4):309-310. doi:10.1001/jama.281.4.309.

Original Contribution |  FREE
David W. Bates, MD; Lucian L. Leape, MD; David J. Cullen, MD; et al.
JAMA. 1998;280(15):1311-1316. doi:10.1001/jama.280.15.1311.

Original Contribution |  FREE
Robert A. Raschke, MD, MS; Bea Gollihare, MS, RN; Thomas A. Wunderlich, RPh; et al.
JAMA. 1998;280(15):1317-1320. doi:10.1001/jama.280.15.1317.

Editorial | 
John P. Burke, MD
JAMA. 1998;280(14):1270-1271. doi:10.1001/jama.280.14.1270.

Original Contribution |  FREE
Mark Monane, MD, MS; Dipika M. Matthias, MBA; Becky A. Nagle, PharmD; et al.
JAMA. 1998;280(14):1249-1252. doi:10.1001/jama.280.14.1249.

From the Food and Drug Administration | 
JAMA. 1998;280(10):872. doi:10.1001/jama.280.10.872.

Brief Report |  FREE
Michael E. Mullins, MD; B. Zane Horowitz, MD; Dennis H. J. Linden, MD; et al.
JAMA. 1998;280(2):157-158. doi:10.1001/jama.280.2.157.

Editorial | 
Edward M. Sellers, MD, PhD
JAMA. 1998;280(2):179-180. doi:10.1001/jama.280.2.179.

Quick Uptakes | 
JAMA. 1998;279(24):1939. doi:10.1001/jama.279.24.1939.

Editorial | 
David W. Bates, MD, MSc
JAMA. 1998;279(15):1216-1217. doi:10.1001/jama.279.15.1216.

Review |  FREE
Jason Lazarou, MSc; Bruce H. Pomeranz, MD, PhD; Paul N. Corey, PhD
JAMA. 1998;279(15):1200-1205. doi:10.1001/jama.279.15.1200.

Special Communication | 
Gordon D. Schiff, MD; T. Donald Rucker, PhD
JAMA. 1998;279(13):1024-1029. doi:10.1001/jama.279.13.1024.

Original Contribution |  FREE
Harold Alan Pincus, MD; Terri L. Tanielian, MA; Steven C. Marcus, MA; et al.
JAMA. 1998;279(7):526-531. doi:10.1001/jama.279.7.526.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Viewpoint  | 
Adulterated Sexual Enhancement Supplements:  More Than Mojo
Pieter A. Cohen, MD; Bastiaan J. Venhuis, PhD
JAMA Internal Medicine
Research Letters  | 
Developing a Model for Attending Physician Workload and Outcomes
Henry J. Michtalik, MD, MPH, MHS; Peter J. Pronovost, MD, PhD; Jill A. Marsteller, PhD, MPP; et al.
JAMA Internal Medicine
Viewpoint  | 
Surrogate Outcomes in Clinical Trials:  A Cautionary Tale
Staffan Svensson, MD, PhD; David B. Menkes, MD, PhD; Joel Lexchin, MSc, MD
JAMA Internal Medicine
Invited Commentary  | 
Are Calcium Supplements Harmful to Cardiovascular Disease?:  Comment on “ Dietary and Supplemental Calcium Intake and Cardiovascular Diseases Mortality: The National Institutes of Health–AARP Diet and Health Study”
Susanna C. Larsson, PhD